Amniocentesis Needle Market (2025 to 2035)
The global amniocentesis needle market was valued at USD 170.5 million in 2024 and has been forecast to expand at a CAGR of 3.2% to end up at USD 239.8 million by 2035. The increasing demand for prenatal genetic testing being driven by a growing median age for first-time mothers as well as greater awareness of genetic disorders is dominating the amniocentesis needle market.
Amniocentesis is an important medical procedure through which prenatal diagnosis is done. This is the process whereby amniotic fluid, surrounding the fetus, is extracted in order to ascertain for the purposes of testing the presence of genetic disorders and the health status. This procedure of amniocentesis is carried out by an amniocentesis needle.
With the growing population worldwide, the rate of pregnancies also increases along with development in healthcare because of which there has been an immense growth in the demand for prenatal tests and products. Rise in the accessibility and adoption of prenatal tests is expected to help in the growth of the amniocentesis needle market as a whole.
Primary drivers that might positively influence amniocentesis needle sales in recent period include medical practitioners' increased referral of patients to undergo the procedure, improving amniocentesis success rates, improved congenital disorders awareness, greater understanding of Down's syndrome, expansion of pregnant women population, and more health research and development funding.
United States holds noteworthy place in amniocentesis needle market at a notable expected value of about USD 35.2 million in 2025 due to advanced healthcare infrastructure, and a greater prevalence of newborn genetic disorders in the region.
| Report Attributes |
Details |
| Amniocentesis Needle Market Size (2024A) |
USD 170.5 Million |
| Estimated Market Value (2025E) |
USD 175.0 Million |
| Forecast Market Value (2035F) |
USD 239.8 Million |
| Global Market Growth Rate (2025 to 2035) |
3.2% CAGR |
| East Asia Market Share (2025) |
24.9% |
| China Market Growth Rate (2025 to 2035) |
3.9% CAGR |
| Key Companies Profiled |
Smiths Medical; Becton Dickinson and Company; Biopsybell Srl; Integra LifeSciences Holdings Corporation; Laboratoire Ccd; Rocket Medical PLC; Medline Industries Inc.; Medtronic PLC; RI.MOS. Srl; Cook Medical LLC; Cooper Surgical Inc.; Tsunami Medical; Other Prominent Players. |
Historic Analysis (2020 to 2024) and Future (2025 to 2035) Pathway Analysis for the Amniocentesis Needle Market
The market for amniocentesis needle grew at a growth rate of 2.6% from 2020 to 2024, and by the end of 2024, it was valued at USD 170.5 million.
Increasing recommendation of amniocentesis procedures by healthcare professionals, growing success rate of amniocentesis, growing awareness of congenital disorders, rising awareness of Down’s syndrome, growing pregnant population, and increasing investments in healthcare research and development are prime factors that could potential uplift amniocentesis needle sales through 2035.
| Historical Report Attributes |
Details |
| Market Size (2020A) |
USD 153.4 million |
| Market Size (2024A) |
USD 170.5 million |
| Historical CAGR (2020 to 2024) |
2.6 % |
| Forecast CAGR (2025 to 2035) |
3.2 % |
- Short Term (2025 to 2028): The primary reason for the increasing demand of amniocentesis needle is increase in demand of prenatal testing, advancements in needle technology, rising awareness of genetic disorder. Expansion in healthcare infrastructure and government initiatives for improving maternal health will drive market growth further.
- Medium Term (2028 to 2032): In the coming years, the increasing global population and higher pregnancies will drive the demand for the prenatal tests. Increasing demand for minimal invasive diagnostic procedure and the high acceptance for diagnostic test in developed countries will drive the amniocentesis needle market. Due to increase in maternal age risk of complications during pregnancy have also increased another reason for growth in amniocentesis needle market.
- Long Term (2032 to 2035): Diabetes is highly prevalent in the general population, and it has had a very serious implication in terms of health complications to many people in the world. There is an extremely high prevalence of gestational diabetes, with the resultant heavy demand for amniocentesis because the serious buildup of amniotic fluid among pregnant women with diabetes. This complicates the pregnancy and increases the risk on the health status of their mothers and their offspring, thus encouraging the sales of amniocentesis needles as they evacuate excess amniotic fluid within the womb, treating pregnant women.
On the back of the aforementioned facts, the amniocentesis needle market is anticipated to grow at a CAGR of 3.2% during the forecast period from 2025 to 2035, According to the Fact.MR, a market research and competitive intelligence provider.
Market Dynamics
What are the Factors Propelling Global Sales of Amniocentesis Needle?
“Increasing incidences of Genetic Disorders across the Globe is Driving the market of Amniocentesis needle market”
Factors that contributes to the demand of amniocentesis needles is the increasing incidence of genetic disorders across the globe. Due to increase awareness expecting parents are now opting for genetic tests to know about the health and well-being of their unborn child.
A serious diagnosis of genetic disorders may be obtained through procedures like amniocentesis, and such diagnoses can be made well in advance of the baby's birth, which is one of the main reasons for utilizing amniocentesis needles. The market for amniocentesis needles is expected to see significant growth as earlier diagnosis of genetic disorders allows for timely treatment.
“The trend of women having children at an older age increases the risk of complications due to which demand of genetic tests increases”
Another major market trend concerning the amniocentesis needle is the rise in age among women giving birth. The risk of genetic disorders is rather high because more first time mothers are crossing the median age. Subsequently, there is a surge in demand for pre-natal testing.
In addition to that, amniocentesis is usually recommended for advanced maternal age as the risk of chromosomal conditions like Down syndrome is higher. The growing demographic trends also drive a high demand for the amniocentesis procedures and motivates health care service providers to develop more all-encompassing options for prenatal care, consequently augmenting amniocentesis needle sales.
What are the major Restraints of Amniocentesis Needle market?
“Minimal invasive procedures which will be better alternative for genetic tests”
However, increasing adoption of minimal invasive procedure in recent years can act as a key limitation for the growth of the amniocentesis needle market. Moreover, NIPTs have the added advantage of ruling out the possibility of infection and cross-contamination, which may become an issue associated with the use of the amniocentesis needles.
With high demand and innovations within minimally invasive technologies, companies are releasing new non-invasive prenatal tests that may negatively affect the growth of the amniocentesis needle market in the near future.
“Concern Regarding Accuracy of Prenatal Tests are genuine”
The test results of prenatal tests have been a matter of controversy for a long time now and the accuracy of these tests is still debatable.
The ambiguity around how frequent a test will provide accurate results and the vague timeframe of pregnancy (i.e. first trimester, second trimester, etc.) that these tests are performed in are other factors that add to skepticism of the credibility of these tests.
All of these factors could potentially slow down the adoption of certain prenatal tests that involve the use of amniocentesis needles and this could constrain amniocentesis needle market potential across the forecast period.
Country-wise Insights
Why there is a steady growth in Amniocentesis Needle market in United States?
“Presence of Developed Healthcare Infrastructure & Rising Frequency of Amniocentesis in the U.S.”
The market in the United States is estimated at USD 35.2 Million in 2025 and is projected to expand at a CAGR of 2.2% through 2035. This market is projected to generate a USD 8.7 Million absolute opportunity from 2025 to 2035.
A substantial number of amniocentesis procedures are being performed, along with growing awareness and availability of prenatal testing. There is enhanced infrastructure in place and a substantial opportunity for healthcare expenditure. Rise in the median age for first-time Mothers and supporting government policies are the prime prospects that would propel amniocentesis needle supply in the country over the next few years.
Other complications of pregnancy are growing nowadays like gestational diabetes and twin-to-twin transfusion syndrome, hence, amniocentesis is inevitable for proper treatment and therefore supports the demand of amniocentesis needles in the health care sector. The existence of industry leaders in this amniocentesis needle market in the country is also likely to have a positive impact on the amniocentesis needle market.
How increase in the median age of first-time mother increased the need of prenatal tests in China?
“Increase in median age of first-time mothers have increased risk of complications and genetic disorders in the new born in china”
The market in the China is estimated to reach USD 34.8 Million in 2035 at a CAGR of 4.4%. This market is projected to generate a USD 12.1 Million absolute opportunity from 2025 to 2035.
Increased prenatal diagnosis awareness, technological advancement to improve safety and comfort in procedures, and increased median age of first-time mothers with associated risks of congenital disorders have boosted the growth of the amniocentesis needle market in China. Increased healthcare infrastructures and a rise in demand for prenatal testing also form the primary factors in the growth of the amniocentesis needle market in China.
Category-wise Insights
Which prenatal test procedure is expected to grow most prominently?
“The procedure of Cordocentesis is expected to witness a significant growth among all the prenatal test procedures”
The procedures in which amniocentesis needle market is used are Amniocentesis, Amnioreduction, Fetal blood transfusions, Amnioinfusion and Cordocentesis.
Betterment in the healthcare area has provided greater care and concern for pregnant women and their health before birth. Among all such invasive prenatal tests, amniocentesis is one of the most recommended tests by doctors around the world, and this should provide a reasonable increase in demand for amniocentesis needles for this procedure over the next few years significantly.
Amniocentesis is expected to account a market share of 37.5% in 2025 and the segment is projected to reach a market valuation of USD 78.9 million by 2035. Such a process gives assistance in the discovery of infections, birth disorders, chromosomal disorders, and other anomalies that could be affecting the health of fetuses and pregnant women.
Although the Cordocentesis process is expected to grow with higher CAGR in the forecast period. It is expected to have a market size of USD 53.7 million in 2035 and the projected CAGR is 3.0% for forecast period 2025 to 2035.
Which needle type is expected to dominate the market share?
“The demand for needles measuring 100-150 mm is anticipated to dominate the market throughout the forecast period.”
Types of needle in global amniocentesis needle market are smaller than 100mm, 100-150mm, larger than 150mm.
Demand for 100-150 mm needles is expected to hold the highest market share throughout the forecast period. These types of needles are used for females with a normal BMI, and the number of pregnant women with this BMI is high, which is expected to bolster sales of 100-150 mm needles over the next few years.
The expected market value of 100-150mm needle is USD 76.1 million in year 2025 and the CAGR is projected to register a CAGR of 3.8% for forecast period 2025 to 2035.
With more and more overweight women continue to gain traction around the globe, this would mean more needles bigger than 150 mm to be required and expected at an approximately 4.7% CAGR due to being administered on females whose BMI is above normal.
Competitive Landscape
Key players in the amniocentesis needle market are Smiths Medical, Becton Dickinson and Company, Biopsybell Srl, Integra LifeSciences Holdings Corporation, Laboratoire Ccd, Rocket Medical PLC, Medline Industries Inc., Medtronic PLC, RI.MOS. Srl, Cook Medical LLC, CooperSurgical Inc., Tsunami Medical and other prominent players.
The global amniocentesis needle market is packed with competition on a local level and this is expected to impact the sales of key companies in the amniocentesis needle marketplace. Major and minor market players are expected to focus on product innovation to advance their sales potential and opt for organic as well as inorganic growth strategies.
This revised amniocentesis needle industry survey by analysts at Fact.MR, a market research and competitive intelligence provider, gives a detailed assessment of opportunities in the amniocentesis needle market for new and established players and has profiled market players such as Laboratoire Ccd, Rocket Medical PLC, and Medline Industries Inc.
- In August 2024, CooperSurgical partnered with a leading ultrasound technology provider to integrate advanced imaging capabilities with their amniocentesis needles. This collaboration aims to improve procedural accuracy and minimize complications, enhancing the overall efficiency of prenatal diagnostics.
Fact.MR has provided detailed information about the price points of key manufacturers of Light Tower Rental positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.
